Flower pollen extract and menopause

What 2 graded rows on flower pollen extract agree on for menopause, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Flower pollen extract page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Flower pollen extract page, with its PubMed record.

Supplement

Flower pollen extract Choose another

2 rows · 459 people

Split. 1 row found no difference and 1 had mixed results.

No difference or mixed

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside. Outlined: mixed results.

From the rows

The best-graded row, grade D, is a meta-analysis of 420 people (2024) and found no difference.

The rows run from 39 to 420 people, published in 2024: 1 pooled review and 1 single study.

1 no difference · 1 mixed

Grade DHot flashes and other menopausal symptoms · No difference
Meta-analysis, 5 studies · n 420 · 2024 · Women with menopausal vasomotor symptoms (1 randomised trial and 4 observational studies)
As used in each study · 3 months
Scores improved from baseline across studies, but when only controlled studies were pooled, the improvements were no longer statistically significant. No significant adverse effects.
Row on the Flower pollen extract page · PubMed 38194609 (opens PubMed)
Grade DHot flashes in breast cancer survivors · Mixed
RCT · n 39 · 2024 · Breast cancer survivors with hot flashes (Italy)
Not stated in the abstract · 3 months
In the pollen group, the number of hot flashes fell from baseline at 3 months (p = 0.02) and rated hot-flash intensity improved; the abstract reports these as changes from baseline and gives no clear comparison with placebo.
Row on the Flower pollen extract page · PubMed 38760920 (opens PubMed)